Study Finds Remdesivir Benefits Patients with COVID-19, Results in Greater Clinical Improvement
The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.